    <!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  
  <!--<meta name="viewport" content="width=device-width, initial-scale=1.0"/>-->
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no"/>
  <title>Finding Dopa</title>
  <link href="https://fonts.googleapis.com/css2?family=PT+Serif:wght@700&family=Orbitron:wght@400;700&display=swap" rel="stylesheet">
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.5.0/css/all.min.css">
  <style>
    html, body {
      margin: 0;
      padding: 0;
      height: 100%;
      font-family: 'PT Serif', serif;
      background: rgba(0, 0, 0, 0.6);
      overflow-x: hidden;
    }

    /* Canvas Background */
    #nebula-canvas {
      position: fixed;
      top: 0;
      left: 0;
      width: 100%;
      height: 100%;
      z-index: -1;
      background: transparent;
      pointer-events: none;
    }

    header {
      background-color: #121212;
      padding: 0px 2px;
      display: flex;
      flex-direction: column;
      align-items: flex-start;
    }

    .top-bar {
      display: flex;
      align-items: center;
      background: #1a1a1a;
      padding: 4px 0;
      height: 40px;
    }

    .home-brand {
      display: flex;
      align-items: center;
      gap: 6px;
      padding: 2px 8px;
      margin-left: 8px;
      text-decoration: none;
      color: #29ff7a;
      font-size: 1.2rem;
      height: 32px;
    }

    .home-brand i {
      font-size: 1.3rem;
    }

    .home-brand:hover {
      color: #00bfff;
    }

    .logo-text {
      font-family: 'PT Serif', serif;
      font-weight: 700;
      font-size: 1.3rem;
      color: white;
    }

    .slider-container {
      width: 100%;
      overflow-x: auto;
      display: flex;
      gap: 10px;
      margin-top: 8px;
      padding-bottom: 10px;
      scrollbar-width: none;
    }

    .slider-container::-webkit-scrollbar {
      display: none;
    }

    .slide {
      flex: 0 0 auto;
      background: #1f1f1f;
      color: white;
      padding: 5px 10px;
      border-radius: 8px;
      white-space: nowrap;
      font-size: 0.95rem;
      font-family: 'PT Serif', serif;
      border: 1px solid #333;
      text-align: center;
      text-decoration: none;
    }

    .slide:hover {
      background: #333;
      color: #29ff7a;
    }

    .slide.active {
      background: black;
      color: #29ff7a;
      border: 2px solid #29ff7a;
    }

    main {
      display: flex;
      flex-direction: column;
      align-items: center;
      text-align: center;
    }

    .hero {
      font-family: 'PT Serif', serif;
      padding: 0 20px;
      margin: -10px 0 1px 0; /* Adjusted margin to move catchphrase higher */
    }

    .hero p {
      font-size: 0.8rem;
      color: #29ff7a;
      margin-bottom: 5px;
      position: relative;
    }

    .hero p::after {
      content: '';
      position: absolute;
      left: 10%;
      right: 10%;
      bottom: -12px;
      border-bottom: 1px solid white;
    }

    .welcome-text {
      font-size: 2rem;
      color: #29ff7a;
    }

    .orb-grid {
      display: flex;
      flex-wrap: wrap;
      justify-content: center;
      gap: 20px;
      margin: 40px 0;
      font-family: 'Orbitron', sans-serif;
    }

    .orb {
      background: rgba(255, 255, 255, 0.15);
      border: 2px solid #29ff7a;
      border-radius: 50%;
      width: 140px;
      height: 140px;
      display: flex;
      align-items: center;
      justify-content: center;
      color: white;
      font-size: 0.9rem;
      text-align: center;
      padding: 10px;
      cursor: pointer;
      transition: transform 0.3s ease;
      box-shadow: 0 0 12px rgba(255, 255, 255, 0.3);
    }

    .orb:hover {
      transform: scale(1.05);
      box-shadow: 0 0 15px #29ff7a;
    }

    .modal {
      display: none;
      position: fixed;
      z-index: 1000;
      left: 0;
      top: 0;
      width: 100vw;
      height: 100vh;
      overflow: auto;
      background-color: rgba(0,0,0,0.85);
    }

    .modal-content {
      background-color: #1a1a1a;
      margin: 10% auto;
      padding: 20px;
      border: 1px solid #888;
      max-width: 600px;
      color: white;
      font-size: 0.95rem;
      font-family: 'PT Serif', serif;
      text-align: left;
      border-radius: 8px;
    }
    
    /*font-family: 'Orbitron', sans-serif;*/

    .close {
      color: #aaa;
      float: right;
      font-size: 24px;
      font-weight: bold;
      cursor: pointer;
    }

    .close:hover,
    .close:focus {
      color: white;
    }

    footer {
      text-align: center;
      padding: 10px;
      background: rgba(0, 0, 0, 0.6);
      color: white;
      font-size: 0.8rem;
    }
  </style>
</head>
<body>
  <!-- Canvas for Particle Animation -->
  <canvas id="nebula-canvas"></canvas>

  <header>
    <div class="top-bar">
      <a href="index.html" class="home-brand" aria-label="Home">
        <i class="fas fa-brain"></i>
        <span class="logo-text">Finding Dopa</span>
      </a>
    </div>
    <div class="slider-container">
      <a href="welcome.html" class="slide">Welcome</a>
      <a href="fix-or-cure.html" class="slide">Fix or Cure?</a>
      <a href="science.html" class="slide">The Science</a>
      <a href="actors.html" class="slide">The Actors</a>
      <a href="news.html" class="slide">Latest News</a>
      <a href="clinical-trials.html" class="slide">Clinical Trials</a>
      <a href="resources.html" class="slide">Resources</a>
      <a href="about.html" class="slide">About</a>
      <a href="disclaimer.html" class="slide">Disclaimer</a>
    </div>
  </header>

  <main>
    <section class="hero">
      <p>A fix for Parkinson's disease is on the way. Keep fighting!</p>
      <h1 class="welcome-text">The Science</h1>
    </section>

    <section class="orb-grid">
      <div class="orb" onclick="openModal('modal4')">iPSCs</div>
      <div class="orb" onclick="openModal('modal1')">Nerve Grafts</div>
      <div class="orb" onclick="openModal('modal2')">MSCs</div>
      <div class="orb" onclick="openModal('modal3')">ANPD001</div>
    </section>
  </main>

<div id="modal4" class="modal">
    <div class="modal-content">
      <span class="close" onclick="closeModal('modal4')">&times;</span>
      <p><strong>iPSCs</strong></p>
      <p>Induced pluripotent stem cells (iPSCs) have become a powerful tool in Parkinson’s disease (PD) research due to their ability to generate patient-specific neurons. Scientists can take a small sample of skin or blood from a person with Parkinson’s and reprogram those cells into iPSCs. These iPSCs can then be directed to become dopamine-producing neurons—the very type of cells that degenerate in PD. This allows researchers to study the patient’s specific form of the disease in a dish, offering valuable insights into the underlying causes and progression of PD at a cellular level.</p>
      <p>Beyond disease modeling, iPSCs hold promise for drug discovery and personalized medicine. By testing potential drugs on neurons derived from a patient’s own iPSCs, researchers can identify which treatments are most effective for that individual, potentially leading to more targeted therapies. Moreover, this platform enables the screening of compounds to find new drugs that protect or restore dopamine neurons, reducing reliance on animal models and speeding up the research process.</p>
      <p>Looking forward, iPSCs may also revolutionize treatment through regenerative medicine. There is ongoing research into transplanting dopamine neurons derived from iPSCs into the brains of people with Parkinson’s. Early trials are exploring whether these lab-grown neurons can integrate into the brain and restore lost function. While challenges remain—such as ensuring safety, preventing immune rejection, and controlling cell behavior—iPSCs represent a hopeful path toward reversing the effects of PD, not just managing its symptoms.</p>
    </div>
  </div>

  <div id="modal1" class="modal">
    <div class="modal-content">
      <span class="close" onclick="closeModal('modal1')">&times;</span>
      <p><strong>Nerve Grafts</strong></p>
      <p>The dopaminergic cells being used in research for Parkinson’s Disease usually come from stem cells — either embryonic stem cells or induced pluripotent stem cells (iPSCs). iPSCs are adult cells (often skin or blood cells) that scientists reprogram to become stem cells, then guide them to become dopamine-producing neurons, similar to the ones lost in Parkinson’s.</p>
      <p></p>These lab-grown cells are promising because they can be made in large numbers and function like real dopamine neurons. However, since they often come from sources other than the patient, they could be attacked by the immune system. That’s why researchers are testing nerve grafts — to protect these new cells and help them survive once implanted in the brain.</p>
      <p></p>This combined approach is still in the clinical trial and experimental stage, but early results are encouraging, and it’s considered one of the most exciting frontiers in Parkinson’s therapy.</p>
    </div>
  </div>

  <div id="modal2" class="modal">
    <div class="modal-content">
      <span class="close" onclick="closeModal('modal2')">&times;</span>
      <p><strong>MSCs (Mesenchymal Stem/Stromal Cells)</strong></p>
      <p>MSCs are adult stem cells capable of reducing inflammation, supporting repair, and secreting neuroprotective factors. Though not naturally dopaminergic, they show promise in Parkinson’s therapy through immunomodulation and support of endogenous repair, with various delivery methods under investigation.</p>
    </div>
  </div>

   <div id="modal3" class="modal">
    <div class="modal-content">
      <span class="close" onclick="closeModal('modal3')">&times;</span>
      <p><strong>ANPD001</strong></p>
      <p>ANPD001 is an investigational autologous dopaminergic neuronal precursor cell (DANPC) therapy being developed by Aspen Neuroscience for the treatment of Parkinson's disease.</p>
<p>Here's a breakdown of what that means:<br>
 * Investigational: This means it is still being studied in clinical trials and is not yet approved for general use by regulatory bodies like the FDA.<br>
 * Autologous: The cells used in the therapy are derived from the patient's own cells (specifically, skin cells that are reprogrammed into induced pluripotent stem cells (iPSCs) and then differentiated into DANPCs). This personalized approach aims to avoid the need for immunosuppressant drugs.<br>
 * Dopaminergic neuronal precursor cell (DANPC) therapy: The therapy involves transplanting cells that are designed to mature into dopamine-producing neurons in the brain. Parkinson's disease is characterized by the loss of these neurons, which leads to motor symptoms.</p>
<p>Key points about ANPD001:<br>
 * Target Disease: Parkinson's disease, a neurodegenerative disorder affecting movement.
 * Mechanism of Action: To replace the dopamine-producing neurons lost in Parkinson's disease.
 * Current Status: It is currently in a Phase 1/2a clinical trial called ASPIRO (Autologous-derived Study of a Parkinson's Investigational Regenerative therapy in an Open-label trial) to assess its safety, tolerability, and preliminary efficacy.<br>
 * Personalized Approach: Because it uses the patient's own cells, it is a personalized therapy.<br>
 * Fast Track Designation: The FDA has granted ANPD001 Fast Track designation, which is intended to expedite the development and review of drugs for serious conditions with unmet medical needs.<br>
 * Early Trial Results: Early findings from the ASPIRO trial indicate that ANPD001 and its delivery have been well-tolerated, with no serious adverse events observed in the initial patient cohorts. There have also been early signs of efficacy, including improvements in motor symptoms and daily functioning.<br>
<p>ANPD001 represents a promising potential regenerative treatment for Parkinson's disease. You can find more information about the ongoing clinical trial (NCT06344026) on clinicaltrials.gov.<br>
</p>
    </div>
  </div>

  <footer>
    &copy; 2025 Finding Dopa. All rights reserved.
  </footer>
  
  <script>
  function openModal(id) {
    document.getElementById(id).style.display = 'block';
  }

  function closeModal(id) {
    document.getElementById(id).style.display = 'none';
  }

  // Highlight current page
  const currentPage = window.location.pathname.split("/").pop();
  document.querySelectorAll('.slider-container .slide').forEach(slide => {
    if (slide.getAttribute('href') === currentPage) {
      slide.classList.add('active');
    }
  });

  // Particle Animation
  const canvas = document.getElementById('nebula-canvas');
  const ctx = canvas.getContext('2d');
  let particlesArray;

  function resizeCanvas() {
    canvas.width = window.innerWidth;
    canvas.height = window.innerHeight;
    // Fill with solid black once at the beginning
    ctx.fillStyle = 'black';
    ctx.fillRect(0, 0, canvas.width, canvas.height);
  }

  window.addEventListener('resize', resizeCanvas);
  resizeCanvas();

  class Particle {
    constructor() {
      this.reset();
    }

    reset() {
      this.x = Math.random() * canvas.width;
      this.y = Math.random() * canvas.height;
      this.size = Math.random() * 2 + 1;
      this.speedX = Math.random() * 0.5 - 0.25;
      this.speedY = Math.random() * 0.5 - 0.25;
      this.opacity = Math.random();
      this.color = `rgba(41, 255, 122, ${this.opacity})`; // green glow
    }

    update() {
      this.x += this.speedX;
      this.y += this.speedY;

      if (this.x < 0 || this.x > canvas.width || this.y < 0 || this.y > canvas.height) {
        this.reset();
      }
    }

    draw() {
      ctx.beginPath();
      ctx.arc(this.x, this.y, this.size, 0, Math.PI * 2);
      ctx.fillStyle = this.color;
      ctx.fill();
    }
  }

  function initParticles() {
    particlesArray = [];
    const numberOfParticles = 150;
    for (let i = 0; i < numberOfParticles; i++) {
      particlesArray.push(new Particle());
    }
  }

  function animateParticles() {
    // Instead of clearing, paint a semi-transparent black layer
    ctx.fillStyle = 'rgba(0, 0, 0, 0.1)';
    ctx.fillRect(0, 0, canvas.width, canvas.height);

    particlesArray.forEach(particle => {
      particle.update();
      particle.draw();
    });

    requestAnimationFrame(animateParticles);
  }

  initParticles();
  animateParticles();
</script>
</body>
</html>
